The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A

Incomplete biological concepts in lymphoid neoplasms still dictate to a large extent the limited availability of efficient targeted treatments, which entertains the mostly unsatisfactory clinical outcomes. Aberrant expression of the embryonal and lymphatic TCL1 family of oncogenes, i.e., the paradig...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Johanna Stachelscheid, Qu Jiang, Marco Herling
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
CLL
Acceso en línea:https://doaj.org/article/70ddfc46c0374e148d64c6eafdab4daf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:70ddfc46c0374e148d64c6eafdab4daf
record_format dspace
spelling oai:doaj.org-article:70ddfc46c0374e148d64c6eafdab4daf2021-11-11T15:33:30ZThe Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A10.3390/cancers132154552072-6694https://doaj.org/article/70ddfc46c0374e148d64c6eafdab4daf2021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5455https://doaj.org/toc/2072-6694Incomplete biological concepts in lymphoid neoplasms still dictate to a large extent the limited availability of efficient targeted treatments, which entertains the mostly unsatisfactory clinical outcomes. Aberrant expression of the embryonal and lymphatic TCL1 family of oncogenes, i.e., the paradigmatic <i>TCL1A</i>, but also <i>TML1</i> or <i>MTCP1</i>, is causally implicated in T- and B-lymphocyte transformation. TCL1A also carries prognostic information in these particular T-cell and B-cell tumors. More recently, the <i>TCL1A</i> oncogene has been observed also in epithelial tumors as part of oncofetal stemness signatures. Although the concepts on the modes of TCL1A dysregulation in lymphatic neoplasms and solid tumors are still incomplete, there are recent advances in defining the mechanisms of its (de)regulation. This review presents a comprehensive overview of TCL1A expression in tumors and the current understanding of its (dys)regulation via genomic aberrations, epigenetic modifications, or deregulation of TCL1A-targeting micro RNAs. We also summarize triggers that act through such transcriptional and translational regulation, i.e., altered signals by the tumor microenvironment. A refined mechanistic understanding of these modes of dysregulations together with improved concepts of TCL1A-associated malignant transformation can benefit future approaches to specifically interfere in TCL1A-initiated or -driven tumorigenesis.Johanna StachelscheidQu JiangMarco HerlingMDPI AGarticleTCL1 oncogeneskinase signalinglymphomaT-PLLCLLBPDCNNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5455, p 5455 (2021)
institution DOAJ
collection DOAJ
language EN
topic TCL1 oncogenes
kinase signaling
lymphoma
T-PLL
CLL
BPDCN
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle TCL1 oncogenes
kinase signaling
lymphoma
T-PLL
CLL
BPDCN
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Johanna Stachelscheid
Qu Jiang
Marco Herling
The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
description Incomplete biological concepts in lymphoid neoplasms still dictate to a large extent the limited availability of efficient targeted treatments, which entertains the mostly unsatisfactory clinical outcomes. Aberrant expression of the embryonal and lymphatic TCL1 family of oncogenes, i.e., the paradigmatic <i>TCL1A</i>, but also <i>TML1</i> or <i>MTCP1</i>, is causally implicated in T- and B-lymphocyte transformation. TCL1A also carries prognostic information in these particular T-cell and B-cell tumors. More recently, the <i>TCL1A</i> oncogene has been observed also in epithelial tumors as part of oncofetal stemness signatures. Although the concepts on the modes of TCL1A dysregulation in lymphatic neoplasms and solid tumors are still incomplete, there are recent advances in defining the mechanisms of its (de)regulation. This review presents a comprehensive overview of TCL1A expression in tumors and the current understanding of its (dys)regulation via genomic aberrations, epigenetic modifications, or deregulation of TCL1A-targeting micro RNAs. We also summarize triggers that act through such transcriptional and translational regulation, i.e., altered signals by the tumor microenvironment. A refined mechanistic understanding of these modes of dysregulations together with improved concepts of TCL1A-associated malignant transformation can benefit future approaches to specifically interfere in TCL1A-initiated or -driven tumorigenesis.
format article
author Johanna Stachelscheid
Qu Jiang
Marco Herling
author_facet Johanna Stachelscheid
Qu Jiang
Marco Herling
author_sort Johanna Stachelscheid
title The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
title_short The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
title_full The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
title_fullStr The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
title_full_unstemmed The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
title_sort modes of dysregulation of the proto-oncogene t-cell leukemia/lymphoma 1a
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/70ddfc46c0374e148d64c6eafdab4daf
work_keys_str_mv AT johannastachelscheid themodesofdysregulationoftheprotooncogenetcellleukemialymphoma1a
AT qujiang themodesofdysregulationoftheprotooncogenetcellleukemialymphoma1a
AT marcoherling themodesofdysregulationoftheprotooncogenetcellleukemialymphoma1a
AT johannastachelscheid modesofdysregulationoftheprotooncogenetcellleukemialymphoma1a
AT qujiang modesofdysregulationoftheprotooncogenetcellleukemialymphoma1a
AT marcoherling modesofdysregulationoftheprotooncogenetcellleukemialymphoma1a
_version_ 1718435186084937728